Research Article
The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated-Interferon versus Entecavir Therapy
Table 1
Baseline clinical characteristics of chronic hepatitis B patients.
| | Characteristics | All patients
| PEG-IFN group
| ETV group
| value |
| | Male, (%) | 59 (66%) | 31 (63%) | 28 (70%) | | Median
Age (yrs)
(Range) | 31
(20–53) | 30
(20–51) | 32
(23–53) | 0.115 |
HBsAg level (log10 IU/mL) | | | | 0.163 |
HBV DNA load (log10 IU/mL) | | | | 0.330 | Median
HBeAg concentration (PEIU/mL)
(Q1, Q3) | 902.26 (454.79, 1398.77) | 878.35 (433.55, 1398.77) | 1067.64 (490.87, 1400.37) | 0.172 | Median
ALT level (U/L)
(Q1, Q3) | 238.80 (124.50, 344.60) | 253.30 (129.85, 357.80) | 223.15 (114.10, 343.93) | 0.775 |
|
|
ALT: alanine aminotransferase; HBsAg: hepatitis B surface antigen; HBeAg: hepatitis B e antigen; value: PEG-IFN group vs. ETV group. |
